Avantor, Inc.

Healthcare

NYSE:AVTR · New York Stock Exchange

Market Cap $6.41B Beta 0.96 P/E (TTM) -11.5

$9.39 -2.80%

-$0.27 today

52W Low $7.27High $15.93

Vol 7.15M · Avg 9.72M

EPS (TTM)-$0.81

Medical - Instruments & Supplies

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

-28.16%

Period High

$15.60

Period Low

$7.41

Latest

$9.39

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Baxter International Inc.

NYSE:BAX

$10.77B

Molina Healthcare, Inc.

NYSE:MOH

$10.43B

Masimo Corporation

NASDAQ:MASI

$9.42B

Henry Schein, Inc.

NASDAQ:HSIC

$9.26B

Bio-Rad Laboratories, Inc.

NYSE:BIO

$7.73B

AptarGroup, Inc.

NYSE:ATR

$7.51B

Repligen Corporation

NASDAQ:RGEN

$7.37B

Grifols, S.A.

NASDAQ:GRFS

$6.46B

Stevanato Group S.p.A.

NYSE:STVN

$4.66B

What is the latest AVTR filing?

The latest filing shown is SD dated May 29, 2026.

How many recent filings does AVTR have?

Intrinsic Alpha currently shows 20 recent filings for AVTR.

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.